Met Life Investment Management, LLC Treace Medical Concepts, Inc. Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 28,046 shares of TMCI stock, worth $213,990. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,046
Previous 28,046
-0.0%
Holding current value
$213,990
Previous $186,000
12.9%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding TMCI
# of Institutions
137Shares Held
39.6MCall Options Held
248KPut Options Held
269K-
Armistice Capital, LLC New York, NY6.2MShares$47.3 Million0.6% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$31 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.27MShares$25 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.74MShares$20.9 Million0.0% of portfolio
-
William Blair Investment Management, LLC Chicago, IL2.39MShares$18.3 Million0.04% of portfolio
About TREACE MEDICAL CONCEPTS, INC.
- Ticker TMCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 55,403,300
- Market Cap $423M
- Description
- Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...